CANO’s Reaction to Filing

Credit Suisse’s https://www.credit-suisse.com quick thoughts on the Third Point (6.4% stake in CANO) filing a 13D that wants the CANO https://canohealth.com Board to commence a review of strategic alternatives with the focus being on a sale of the company. The investment firm believes that a properly run sales process is likely to result in offers representing a substantial premium to the current share price. …Continue reading